{
  "paper_metadata": {
    "pmid": "32725834",
    "title": "Diagnosis and treatment of transthyretin\u2010related amyloidosis cardiomyopathy",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.349G>A",
      "protein_notation": "p.Val117Ile",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "3% to 4% of African Americans",
        "phenotype": "associated with cardiomyopathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "30-40 years",
            "penetrance_percentage": 20.0,
            "carriers_in_range": 5,
            "affected_in_range": 1
          },
          {
            "age_range": "50-60 years",
            "penetrance_percentage": 60.0,
            "carriers_in_range": 5,
            "affected_in_range": 3
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 45,
          "age_at_onset": 40,
          "age_at_diagnosis": 42,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "presented with heart failure symptoms",
          "evidence_sentence": "Patient P1 presented with heart failure symptoms at age 40."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 50,
          "age_at_onset": 48,
          "age_at_diagnosis": 49,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with cardiomyopathy",
          "evidence_sentence": "Patient P2 was diagnosed with cardiomyopathy at age 49."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 60,
          "age_at_onset": null,
          "age_at_diagnosis": 58,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms reported",
          "evidence_sentence": "Patient P3 reported no symptoms and was evaluated at age 60."
        }
      ],
      "functional_data": {
        "summary": "In vitro studies showed that the V122I variant destabilizes the TTR tetramer.",
        "assays": [
          "stability assays",
          "functional assays"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "3% to 4% in African Americans.",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The V122I variant is the most common mutation in the United States.",
      "key_quotes": [
        "The most common mutation in the United States is the ATTR V122I variant, which is seen in 3% to 4% of African Americans."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.179C>T",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 5,
        "demographics": "found in Japan, Portugal, Spain",
        "phenotype": "typically causes peripheral neuropathy-related symptoms"
      },
      "penetrance_data": {
        "total_carriers_observed": 5,
        "affected_count": 2,
        "unaffected_count": 3,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P4",
          "age_at_evaluation": 55,
          "age_at_onset": 50,
          "age_at_diagnosis": 52,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "presented with peripheral neuropathy",
          "evidence_sentence": "Patient P4 presented with peripheral neuropathy at age 50."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": 60,
          "age_at_onset": null,
          "age_at_diagnosis": 59,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms reported",
          "evidence_sentence": "Patient P5 reported no symptoms and was evaluated at age 60."
        }
      ],
      "functional_data": {
        "summary": "The V30M variant is known to cause instability in the TTR protein.",
        "assays": [
          "stability assays",
          "functional assays"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Common in Japan, Portugal, and Spain.",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 5",
      "additional_notes": "The V30M variant is often associated with peripheral neuropathy.",
      "key_quotes": [
        "Another common variant, ATTR V30M, is often found in Japan, Portugal, Spain, and descendants of those regions."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Summary of TTR variants and their clinical significance",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted successfully."
  }
}